Soligenix invited to present at upcoming investor conferences

Princeton, n.j. , oct. 16, 2024 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the company will be providing a corporate update at the upcoming investor conferences on the dates below.
SNGX Ratings Summary
SNGX Quant Ranking